Structure of a thrombospondin C‐terminal fragment reveals a novel calcium core in the type 3 repeats
暂无分享,去创建一个
Josephine C. Adams | Marc Kvansakul | E. Hohenester | M. Kvansakul | Erhard Hohenester | Josephine C Adams | J. Adams
[1] J. Lawler,et al. Diverse mechanisms for cell attachment to platelet thrombospondin. , 1993, Journal of cell science.
[2] L. Ala‐Kokko,et al. Mutations in Cartilage Oligomeric Matrix Protein Causing Pseudoachondroplasia and Multiple Epiphyseal Dysplasia Affect Binding of Calcium and Collagen I, II, and IX* , 2001, The Journal of Biological Chemistry.
[3] Chris Sander,et al. Dali/FSSP classification of three-dimensional protein folds , 1997, Nucleic Acids Res..
[4] J. Adams,et al. Thrombospondins: multifunctional regulators of cell interactions. , 2001, Annual review of cell and developmental biology.
[5] C. Prange,et al. Mutations in exon 17B of cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasia , 1995, Nature Genetics.
[6] J. Lawler,et al. Evidence for calcium-sensitive structure in platelet thrombospondin. Isolation and partial characterization of thrombospondin in the presence of calcium. , 1982, The Journal of biological chemistry.
[7] W. Frazier,et al. Identification of a new cell adhesion motif in two homologous peptides from the COOH-terminal cell binding domain of human thrombospondin. , 1993, The Journal of biological chemistry.
[8] Josephine C. Adams,et al. Trimeric assembly of the C-terminal region of thrombospondin-1 or thrombospondin-2 is necessary for cell spreading and fascin spike organisation. , 2002, Journal of cell science.
[9] V. Dixit,et al. Thrombospondin functions as a cytoadhesion molecule for human hematopoietic progenitor cells. , 1990, Blood.
[10] R. Hynes,et al. An integrin receptor on normal and thrombasthenic platelets that binds thrombospondin. , 1989, Blood.
[11] D. Mosher,et al. A Polymorphism in Thrombospondin-1 Associated with Familial Premature Coronary Heart Disease Causes a Local Change in Conformation of the Ca2+-binding Repeats* , 2003, The Journal of Biological Chemistry.
[12] J. Lawler,et al. Cartilage Oligomeric Matrix Protein Is a Calcium-binding Protein, and a Mutation in Its Type 3 Repeats Causes Conformational Changes* , 2000, The Journal of Biological Chemistry.
[13] Thilo Stehle,et al. Crystal Structure of the Extracellular Segment of Integrin αVβ3 in Complex with an Arg-Gly-Asp Ligand , 2002, Science.
[14] Josephine C. Adams,et al. A Role for Syndecan-1 in Coupling Fascin Spike Formation by Thrombospondin-1 , 2001, The Journal of cell biology.
[15] W. Frazier,et al. An amyloid-like C-terminal domain of thrombospondin-1 displays CD47 agonist activity requiring both VVM motifs. , 2003, Biochemistry.
[16] A. Joachimiak,et al. Crystal structure of the TSP-1 type 1 repeats , 2002, The Journal of cell biology.
[17] K. Drickamer,et al. Lectin-like proteins in model organisms: implications for evolution of carbohydrate-binding activity. , 2001, Glycobiology.
[18] D. Keene,et al. A Cartilage Oligomeric Matrix Protein Mutation Associated with Pseudoachondroplasia Changes the Structural and Functional Properties of the Type 3 Domain* , 2000, The Journal of Biological Chemistry.
[19] R. Kretsinger,et al. Evolution of the EF-hand family of proteins. , 1994, Annual review of biophysics and biomolecular structure.
[20] E. Brown,et al. Integrin-associated Protein Is a Receptor for the C-terminal Domain of Thrombospondin (*) , 1996, The Journal of Biological Chemistry.
[21] J. Lawler,et al. Cooperative binding of calcium to thrombospondin. The effect of calcium on the circular dichroism and limited tryptic digestion of thrombospondin. , 1983, The Journal of biological chemistry.
[22] Josephine C. Adams,et al. The thrombospondin family , 1993, Current Biology.
[23] J. Connolly,et al. The structure of human platelet thrombospondin. , 1985, The Journal of biological chemistry.
[24] R M Esnouf,et al. An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. , 1997, Journal of molecular graphics & modelling.
[25] R. Hynes,et al. An integrin receptor on normal and thrombasthenic platelets that binds thrombospondin [see comments] , 1989 .
[26] P. Bornstein,et al. Thrombospondins 1 and 2 function as inhibitors of angiogenesis. , 2003, Matrix biology : journal of the International Society for Matrix Biology.
[27] D. Heinegård,et al. Cartilage Oligomeric Matrix Protein Shows High Affinity Zinc-dependent Interaction with Triple Helical Collagen* , 1998, The Journal of Biological Chemistry.
[28] M. Paulsson,et al. Thrombospondin-4 Binds Specifically to Both Collagenous and Non-collagenous Extracellular Matrix Proteins via Its C-terminal Domains* , 2000, The Journal of Biological Chemistry.
[29] J. Lawler. The functions of thrombospondin-1 and-2. , 2000, Current opinion in cell biology.
[30] M. Briggs,et al. Pseudoachondroplasia and multiple epiphyseal dysplasia: Mutation review, molecular interactions, and genotype to phenotype correlations , 2002, Human mutation.
[31] D. Mosher,et al. Interactions among the three structural motifs of the C-terminal region of human thrombospondin-2. , 2003, Biochemistry.
[32] R. Hynes,et al. The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites and homologies with several different proteins , 1986, The Journal of cell biology.
[33] R. Timpl,et al. Properties of the extracellular calcium binding module of the proteoglycan testican , 1997, FEBS letters.
[34] G. Schneider,et al. Crystal Structure of the Carbohydrate Recognition Domain of p58/ERGIC-53, a Protein Involved in Glycoprotein Export from the Endoplasmic Reticulum* , 2002, The Journal of Biological Chemistry.
[35] E A Merritt,et al. Raster3D: photorealistic molecular graphics. , 1997, Methods in enzymology.
[36] V. Dixit,et al. Properties of recombinant mouse thrombospondin 2 expressed in Spodoptera cells. , 1994, The Journal of biological chemistry.
[37] S. Kochanek,et al. Pseudoachondroplasia is caused through both intra- and extracellular pathogenic pathways. , 2002, The Journal of clinical investigation.
[38] J. Zou,et al. Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.
[39] R. R. Cooper,et al. A unique rough surfaced endoplasmic reticulum inclusion in pseudoachondroplasia. , 1972, Laboratory investigation; a journal of technical methods and pathology.
[40] A. Olsen,et al. Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene , 1995, Nature Genetics.
[41] M Freedman,et al. Single Nucleotide Polymorphisms in Multiple Novel Thrombospondin Genes May Be Associated With Familial Premature Myocardial Infarction , 2001, Circulation.
[42] N. Morris,et al. The Fate of Cartilage Oligomeric Matrix Protein Is Determined by the Cell Type in the Case of a Novel Mutation in Pseudoachondroplasia* , 1997, The Journal of Biological Chemistry.
[43] J. Pimanda,et al. The von Willebrand factor-reducing activity of thrombospondin-1 is located in the calcium-binding/C-terminal sequence and requires a free thiol at position 974. , 2002, Blood.
[44] Kozo Nakamura,et al. Novel types of COMP mutations and genotype-phenotype association in pseudoachondroplasia and multiple epiphyseal dysplasia , 2002, Human Genetics.
[45] W. Wilcox,et al. Physiological and Pathological Secretion of Cartilage Oligomeric Matrix Protein by Cells in Culture* , 1998, The Journal of Biological Chemistry.
[46] R J Read,et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.
[47] L. Prasad,et al. Structures of the lectin IV of Griffonia simplicifolia and its complex with the Lewis b human blood group determinant at 2.0 A resolution. , 1994, Journal of molecular biology.
[48] K. Kadler,et al. Cartilage Oligomeric Matrix Protein Interacts with Type IX Collagen, and Disruptions to These Interactions Identify a Pathogenetic Mechanism in a Bone Dysplasia Family* , 2001, The Journal of Biological Chemistry.
[49] A. Harms,et al. Disulfide Connectivity of Recombinant C-terminal Region of Human Thrombospondin 2* , 2001, The Journal of Biological Chemistry.
[50] K. Skorstengaard,et al. Disulfides modulate RGD-inhibitable cell adhesive activity of thrombospondin , 1992, The Journal of cell biology.
[51] R. Hynes,et al. Cell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors , 1988, The Journal of cell biology.
[52] J. Lawler,et al. Cell-type specific adhesive interactions of skeletal myoblasts with thrombospondin-1. , 1994, Molecular biology of the cell.
[53] J. Putkey,et al. Disease-causing Mutations in Cartilage Oligomeric Matrix Protein Cause an Unstructured Ca2+ Binding Domain* , 2002, The Journal of Biological Chemistry.
[54] Collaborative Computational,et al. The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.
[55] J. Thornton,et al. PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .
[56] Josephine C. Adams,et al. Characterisation of Drosophila thrombospondin defines an early origin of pentameric thrombospondins. , 2003, Journal of molecular biology.
[57] H. Mori,et al. Mutation (D472Y) in the type 3 repeat domain of cartilage oligomeric matrix protein affects its early vesicle trafficking in endoplasmic reticulum and induces apoptosis. , 2003, The American journal of pathology.
[58] D. Mosher,et al. Calcium Ion Binding to Thrombospondin 1 (*) , 1995, The Journal of Biological Chemistry.